Wellington Management Group Portfolio holdings
Wellington Management Group, founded in 1928 by Walter L. Morgan and headquartered in Boston, Massachusetts, is one of the world’s largest independent asset management firms, overseeing trillions in assets for a diverse client base including pension funds, endowments, and mutual fund investors. Renowned for its active management approach, Wellington offers a broad range of investment strategies across equities, fixed income, multi-asset, and alternative investments, emphasizing deep research and long-term partnerships with clients. The firm gained early fame for launching the Wellington Fund, one of the first balanced mutual funds, and has since maintained a reputation for disciplined, collaborative portfolio management. With a global presence and a focus on customized solutions, Wellington remains a trusted name in institutional and retail investing.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$1.52B |
| 2 |
Apple
AAPL
|
+$1B |
| 3 |
MetLife
MET
|
+$797M |
| 4 |
Chevron
CVX
|
+$491M |
| 5 |
Applied Materials
AMAT
|
+$471M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Teva Pharmaceutical Industries Limited
TEVA
|
+$937M |
| 2 |
FRX
FOREST LABORATORIES INC
FRX
|
+$706M |
| 3 |
Gilead Sciences
GILD
|
+$618M |
| 4 |
IBM
IBM
|
+$567M |
| 5 |
AstraZeneca
AZN
|
+$484M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 22.76% |
| 2 | Financials | 14.37% |
| 3 | Technology | 13.2% |
| 4 | Energy | 12.26% |
| 5 | Industrials | 10.59% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
1
Merck
MRK
$359B
| $8.82B | 2.37% |
159,811,363
-4,811,402
| -3% | -$262M |
2013 Q2
4 quarters
|
|
2
Wells Fargo
WFC
$253B
| $6.75B | 1.82% |
128,418,929
-8,266,987
| -6% | -$416M |
2013 Q2
4 quarters
|
|
|
3
Chevron
CVX
$416B
| $6.34B | 1.71% |
48,599,596
+3,946,888
| +9% | +$491M |
2013 Q2
4 quarters
|
|
|
4
Bristol-Myers Squibb
BMY
$121B
| $5.82B | 1.57% |
119,946,967
+30,778,426
| +35% | +$1.52B |
2013 Q2
4 quarters
|
|
5
ExxonMobil
XOM
$695B
| $5.72B | 1.54% |
56,846,763
+551,351
| +1% | +$55.6M |
2013 Q2
4 quarters
|
|
6
Microsoft
MSFT
$3.97T
| $5.51B | 1.48% |
132,117,141
-5,336,335
| -4% | -$216M |
2013 Q2
4 quarters
|
|
7
Johnson & Johnson
JNJ
$630B
| $4.74B | 1.27% |
45,309,314
-174,697
| -0.4% | -$17.7M |
2013 Q2
4 quarters
|
|
8
JPMorgan Chase
JPM
$885B
| $4.23B | 1.14% |
73,445,928
-2,377,023
| -3% | -$134M |
2013 Q2
4 quarters
|
|
9
UnitedHealth
UNH
$340B
| $4.18B | 1.13% |
51,191,982
-2,222,871
| -4% | -$175M |
2013 Q2
4 quarters
|
|
10
Eli Lilly
LLY
$1.05T
| $4.06B | 1.09% |
65,291,855
-47,999
| -0.1% | -$2.86M |
2013 Q2
4 quarters
|
|
|
11
Apple
AAPL
$4.91T
| $4.05B | 1.09% |
174,174,932
+47,085,536
| +37% | +$1B |
2013 Q2
4 quarters
|
|
12
Verizon
VZ
$173B
| $3.82B | 1.03% |
78,036,220
+7,840,319
| +11% | +$380M |
2013 Q2
4 quarters
|
|
13
PNC Financial Services
PNC
$87.5B
| $3.72B | 1% |
41,726,844
-2,965,174
| -7% | -$253M |
2013 Q2
4 quarters
|
|
14
Medtronic
MDT
$113B
| $3.63B | 0.98% |
56,902,964
+3,816,908
| +7% | +$232M |
2013 Q2
4 quarters
|
|
15
CVS Health
CVS
$110B
| $3.5B | 0.94% |
46,381,199
-4,548,265
| -9% | -$344M |
2013 Q2
4 quarters
|
|
16
Blackrock
BLK
$168B
| $3.22B | 0.87% |
10,073,530
-46,254
| -0.5% | -$14.2M |
2013 Q2
4 quarters
|
|
17
Alphabet (Google) Class C
GOOG
$4.25T
| $3B | 0.81% |
104,077,703
-2,555,532
| -2% | -$69.3M |
2013 Q2
4 quarters
|
|
18
United Parcel Service
UPS
$80.5B
| $2.92B | 0.78% |
28,406,131
+1,237,534
| +5% | +$124M |
2013 Q2
4 quarters
|
|
19
Pfizer
PFE
$161B
| $2.85B | 0.77% |
101,229,256
+9,293,963
| +10% | +$265M |
2013 Q2
4 quarters
|
|
20
Comcast
CMCSA
$73.3B
| $2.84B | 0.76% |
105,903,656
+17,003,282
| +19% | +$437M |
2013 Q2
4 quarters
|
|
21
Lowe's Companies
LOW
$104B
| $2.83B | 0.76% |
58,876,055
+1,235,557
| +2% | +$57.6M |
2013 Q2
4 quarters
|
|
22
Chubb
CB
$132B
| $2.82B | 0.76% |
27,164,296
+97,263
| +0.4% | +$9.96M |
2013 Q2
4 quarters
|
|
23
Intel
INTC
$553B
| $2.64B | 0.71% |
85,493,697
+7,300,712
| +9% | +$200M |
2013 Q2
4 quarters
|
|
24
RTX Corp
RTX
$251B
| $2.57B | 0.69% |
35,360,559
+2,643,394
| +8% | +$195M |
2013 Q2
4 quarters
|
|
25
Cisco
CSCO
$467B
| $2.55B | 0.69% |
102,808,339
+1,108,778
| +1% | +$26.4M |
2013 Q2
4 quarters
|
|
Similar funds
Wellington Management Group's Q2 2014 Portfolio in Review
As of Q2 2014, Wellington Management Group held 2,343 positions worth $372B, up 3.2% from $360B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Wellington Management Group's Q2 2014 filing shows 204 new, 793 increased, 921 reduced and 197 closed positions. Its largest new stake was IMS HEALTH HLDGS INC COM STK (DE): 18,373,009 shares worth $472M. The largest sale was Teva Pharmaceutical Industries Limited, an estimated $937M.
By sector, the portfolio is most concentrated in Healthcare at 23% of assets, down from 23% a quarter earlier, followed by Financials and Technology.
- Wellington Management Group's largest Q2 2014 buy was IMS HEALTH HLDGS INC COM STK (DE): 18,373,009 shares worth $472M.
- Wellington Management Group added most to Bristol-Myers Squibb in Q2 2014, an estimated $1.52B increase.
- Wellington Management Group's biggest Q2 2014 reduction was Teva Pharmaceutical Industries Limited, cutting an estimated $937M.
- Wellington Management Group fully exited lululemon athletica in Q2 2014, selling an estimated $456M.
- Wellington Management Group's ten largest holdings make up 15% of its $372B portfolio in Q2 2014.
- Wellington Management Group opened 204 new positions and closed 197 in Q2 2014.
- Wellington Management Group's portfolio value rose 3.2% quarter-over-quarter to $372B.
Based on Wellington Management Group's 13F filing for Q2 2014, filed 14 Aug 2014.